Literature DB >> 3300709

The use of a monoclonal antibody for the rapid purification of kidney neutral endopeptidase ("enkephalinase") solubilized in octyl glucoside.

M Aubry, A Berteloot, A Beaumont, B P Roques, P Crine.   

Abstract

The neutral endopeptidase ("enkephalinase") of the rabbit brush border membrane has been purified to homogeneity by a rapid immunoaffinity method using a monoclonal antibody. In contrast with other methods used so far, a complete extraction of enkephalinase from the brush border membrane can be achieved with octyl glucoside, without loss of activity. The solubilized enzyme can be selectively separated from the other proteins in a single step using an immunoaffinity column consisting of the monoclonal antibody covalently linked to Sepharose CL-4B. It is demonstrated that enkephalinase can then be recovered in an active form by elution at low pH. The purified enzyme obtained by this method is completely inhibited by thiorphan and appears as a single 94,000 dalton protein after polyacrylamide gel electrophoresis under denaturing and reducing conditions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300709     DOI: 10.1139/o87-050

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  10 in total

1.  Secretion of a functional soluble form of neutral endopeptidase-24.11 from a baculovirus-infected insect cell line.

Authors:  F Fossiez; G Lemay; N Labonté; F Parmentier-Lesage; G Boileau; P Crine
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

2.  Proteolytic processing of the alpha-subunit of rat endopeptidase-24.18 by furin.

Authors:  P E Milhiet; S Chevallier; D Corbeil; N G Seidah; P Crine; G Boileau
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

3.  Identification of the cysteine residues implicated in the formation of alpha 2 and alpha/beta dimers of rat meprin.

Authors:  S Chevallier; J Ahn; G Boileau; P Crine
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

4.  Highly sensitive and selective fluorescence assays for rapid screening of endothelin-converting enzyme inhibitors.

Authors:  N Luciani; H de Rocquigny; S Turcaud; A Romieu; B P Roques
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

5.  Identification of an endothelin-converting enzyme-2-specific fluorigenic substrate and development of an in vitro and ex vivo enzymatic assay.

Authors:  Tanja Ouimet; Sou-Vinh Orng; Hervé Poras; Khatuna Gagnidze; Lakshmi A Devi; Marie-Claude Fournié-Zaluski; Bernard P Roques
Journal:  J Biol Chem       Date:  2010-08-31       Impact factor: 5.157

6.  Secretion of a type II integral membrane protein induced by mutation of the transmembrane segment.

Authors:  I Lemire; C Lazure; P Crine; G Boileau
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

7.  Characterization of neutral endopeptidase 24.11 in dog glomeruli.

Authors:  C Landry; P Santagata; W Bawab; M C Fournié-Zaluski; B P Roques; P Vinay; P Crine
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

8.  Expression of rat endopeptidase-24.18 in COS-1 cells: membrane topology and activity.

Authors:  P E Milhiet; D Corbeil; V Simon; A J Kenny; P Crine; G Boileau
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

9.  Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.

Authors:  M C Fournié-Zaluski; W Gonzalez; S Turcaud; I Pham; B P Roques; J B Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

10.  Development of [125I]RB104, a potent inhibitor of neutral endopeptidase 24.11, and its use in detecting nanogram quantities of the enzyme by "inhibitor gel electrophoresis".

Authors:  M C Fournié-Zaluski; J M Soleilhac; S Turcaud; R Laï-Kuen; P Crine; A Beaumont; B P Roques
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.